STRIDES PHARMA SCIENCE LTD.
|
Market Cap.(`)
|
5884.13 Cr.
|
P/BV
|
2.59
|
Book Value (`)
|
246.48
|
|
52 Week High/Low ( ` )
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Book Closure
|
09/09/2024
|
EPS (`)
|
0.00
|
Div Yield (%)
|
0.39
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 3891.02 | 3607.67 | 3022.06 | 3251.16 | 2656.75 |
| Other Operating Revenues | 160.10 | 80.72 | 48.19 | 64.72 | 95.23 |
| Total Operating Revenues | 4051.12 | 3688.39 | 3070.25 | 3315.87 | 2751.97 |
| | | | | | |
| Other Income | 39.70 | 90.33 | 131.99 | 51.43 | 53.11 |
| Total Revenue | 4090.83 | 3778.72 | 3202.24 | 3367.30 | 2805.08 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1341.11 | 1441.68 | 1090.93 | 1390.42 | 1020.35 |
| Purchase Of Stock-In Trade | 283.45 | 187.87 | 316.11 | 296.08 | 146.94 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 15.94 | -2.67 | 95.28 | -353.71 | -44.81 |
| Employee Benefit Expenses | 751.13 | 732.02 | 646.91 | 550.15 | 442.56 |
| Finance Costs | 314.45 | 261.14 | 176.74 | 150.07 | 155.72 |
| Depreciation And Amortisation Expenses | 220.68 | 243.25 | 233.01 | 206.29 | 173.70 |
| Other Expenses | 916.23 | 899.30 | 941.13 | 798.10 | 671.03 |
| Total Expenses | 3842.99 | 3762.60 | 3500.11 | 3037.39 | 2565.50 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 247.84 | 16.12 | -297.88 | 329.91 | 239.59 |
| | | | | | |
| Exceptional Items | -189.05 | -17.03 | -243.83 | 43.35 | -77.68 |
| Profit/Loss Before Tax | 58.79 | -0.92 | -541.70 | 373.26 | 161.91 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 37.31 | -31.70 | -150.44 | 21.45 | 28.01 |
| Deferred Tax | -5.72 | -23.60 | -27.82 | 10.20 | -16.68 |
| Total Tax Expenses | 31.59 | -55.30 | -178.26 | 31.65 | 11.32 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 27.20 | 54.38 | -363.44 | 341.61 | 150.59 |
| | | | | | |
| Profit/Loss From Continuing Operations | 27.20 | 54.38 | -363.44 | 341.61 | 150.59 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 54.22 | 18.57 | 0.00 | 13.94 | -6.17 |
| Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 0.00 | 0.00 | 6.59 |
| Net Profit/Loss From Discontinuing Operations | 54.22 | 18.57 | 0.00 | 13.94 | -12.76 |
| Profit/Loss For The Period | 81.42 | 72.95 | -363.44 | 355.55 | 137.83 |
| | | | | | |
| Minority Interest | 23.70 | 9.70 | 14.04 | 10.71 | 5.80 |
| Share Of Profit/Loss Of Associates | -175.74 | -285.28 | -110.81 | -97.82 | -107.23 |
| Consolidated Profit/Loss After MI And Associates | -70.61 | -202.64 | -460.21 | 268.44 | 36.39 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -7.76 | -22.49 | -51.28 | 29.96 | 5.68 |
| Diluted EPS (Rs.) | -7.76 | -22.49 | -51.28 | 29.92 | 5.68 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 13.55 | 0.00 | 0.00 | 17.92 | 156.30 |